Latest filing published 29 Apr 2026 for GSK plc.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Diana Conrad, Chief People Officer of GSK plc, files more purchases than sales: 8 purchases, all without a reported amount, against 4 sales, 3 of them with an amount, EUR 1,147,932 with a median of EUR 349,635. Purchases make up 67% of open-market trades, and all 8 fall in the last twelve months, which hold 20 filings in total, with 2 sales.
The two largest sales share the same date, February 9, 2026: EUR 680,987 and EUR 349,635. The third, EUR 117,310, dates from February 17, 2025.
The record holds 60 filings published from October 13, 2023 to April 29, 2026, 48 of them grants. By year: 3 in 2023, 19 in 2024, 18 in 2025 and 20 in 2026.
Trades by Conrad within 30 days of colleagues at GSK plc number 11, 10 and 9. Of which in the same direction: 9, 8 and 7. Names in order: Shobie Ramakrishnan, Wendy Becker and Maya Martinez-Davis. The median publication delay is 4 days.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 60 declarations